Evaluation of Peripheral Nerve Stimulation for Acute Treatment of Migraine Pain

Completed · Not applicable · Has a placebo group

Conditions studied: Episodic Migraine

In brief

Clinical study to determine the responder rate of the TheraNova Migraine Treatment System to that of a sham control treatment.

Key facts

Study ID
NCT04166045
Run by
Theranova, L.L.C.
People needed
20
Starts
2020-06-12
Expected to finish
2021-04-29
Last updated by the study team
2021-07-26

Who can join

Age: 18 and older, up to 100. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.